2002
DOI: 10.1042/0264-6021:3620061
|View full text |Cite
|
Sign up to set email alerts
|

Phytanic acid, a novel activator of uncoupling protein-1 gene transcription and brown adipocyte differentiation

Abstract: Phytanic acid (3,7,11,15-tetramethylhexadecanoic acid) is a phytol-derived branched-chain fatty acid present in dietary products. Phytanic acid increased uncoupling protein-1 (UCP1) mRNA expression in brown adipocytes differentiated in culture. Phytanic acid induced the expression of the UCP1 gene promoter, which was enhanced by co-transfection with a retinoid X receptor (RXR) expression vector but not with other expression vectors driving peroxisome proliferator-activated receptor (PPAR)alpha, PPARgamma or a … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
32
0
2

Year Published

2002
2002
2018
2018

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 28 publications
(35 citation statements)
references
References 39 publications
1
32
0
2
Order By: Relevance
“…These results indicate that the effect on glucose uptake is not due to RXR activation, the common partner of these nuclear receptors. The differences between these nuclear receptors have been previously observed, for instance, adipogenesis was inhibited by an RAR-mediated event [29,30], whereas RXR-specific agonists promoted adipocyte differentiation [27].…”
Section: Discussionmentioning
confidence: 76%
See 1 more Smart Citation
“…These results indicate that the effect on glucose uptake is not due to RXR activation, the common partner of these nuclear receptors. The differences between these nuclear receptors have been previously observed, for instance, adipogenesis was inhibited by an RAR-mediated event [29,30], whereas RXR-specific agonists promoted adipocyte differentiation [27].…”
Section: Discussionmentioning
confidence: 76%
“…We used the following dosages: rosiglitazone as PPARγ agonist, 10 μmol/l, a dose previously used in brown adipocytes [19]; TTNPB as RAR agonist, 10 μmol/l; and phytanic acid as RXR agonist, 20 μmol/l. The latter two doses are similar to those used in other studies in vitro [27]. To activate NR1HR we tested the synthetic compounds T0901317 and GW3965 at the optimal doses of 3 and 15 μmol/l, respectively, calculated from dose-response experiments (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Previous work has shown that the gene promoter of UCP1, the speci¢c molecular marker of di¡er-entiated brown adipocytes, was highly sensitive to phytanic acid [8]. To test the action of pristanic acid on the UCP1 gene promoter, the HIB-1B brown adipocyte-derived cell line was used.…”
Section: E¡ects Of Pristanic Acid and Phytanic Acid On Ucp1 Genementioning
confidence: 99%
“…PA has also been shown to induce adipocyte differentiation [129,130]. The origin of PA, which can also give rise to Refsum syndrome in which phytanoyl-CoA-hydroxylase is defective, is somewhat unclear [131].…”
mentioning
confidence: 99%